Form Type: 4

Accession Number:0001209191-21-054958
Original Submission Date:

Reporting Person:


Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-09-01 A 23,754 a $0.00 248,858 direct
COMMON STOCK 2021-09-01 S 11,220 d $20.68 237,638 direct
COMMON STOCK 2021-09-01 0 $0.00 176,982 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
f1 these shares of common stock were issued in connection with the vesting of restricted stock units ("rsus"), which were originally granted on november 26, 2019, upon the satisfaction of a performance-based vesting condition.
f2 includes 634,602 of the issuer's chess depositary interests ("cdis"). cdis are units of beneficial ownership in shares of common stock of the issuer that are publicly traded on the australian securities exchange (the "asx") and held by chess depositary nominees pty, limited, a subsidiary of asx limited, the company that operates the asx. five cdis are equivalent to one share of common stock and have all the rights and privileges of common stock. the reporting person holds 634,602 cdis, which translate into 126,920 of the shares of common stock set forth above.
f3 includes 47,507 unvested rsus, each representing a contingent right to be issued one share of common stock, that are subject to time-based vesting criteria. these rsus were originally rights to receive ordinary shares of avita medical, ltd., an australian public company and predecessor to the issuer ("predecessor"). pursuant to a scheme of arrangement, completed on june 30, 2020, such rsus became rights to be issued shares of common stock of the issuer in the ratio of one share of common stock for every 100 ordinary shares of predecessor to which the holder would otherwise have been entitled. the rsus vest on june 1, 2022.
f4 represents shares sold in order to pay withholding taxes due in connection with the vesting of rsus.
f5 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $20.36 to $20.82. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of the shares of common stock sold at each separate price within the ranges set forth in this footnote to this form 4.
f6 consists of 631,525 cdis, which translate into 126,305 shares of common stock, and 50,677 shares of common stock, which were previously transferred to the reporting person's spouse pursuant to a property settlement agreement entered into in connection with a divorce. the reporting person and his spouse subsequently remarried.

Elevate your investments